Navigation Links
New Treatment For Obstructive Sleep Apnea Now Available In Canada
Date:11/19/2012

SA. The device has been shown to be clinically effective in a series of peer reviewed studies. It is an easy to use, non-invasive and disposable treatment that works across mild, moderate, and severe OSA. Provent Therapy utilizes nasal expiratory positive airway pressure (EPAP) to keep a patient's airway open during sleep and has been clinically proven in numerous studies to reduce sleep apnea. It incorporates a novel MicroValve design that is placed over the nostrils and secured with hypoallergenic adhesive. During inhalation, the valve opens allowing nearly unobstructed airflow. During exhalation, the valve closes, limiting airflow through small openings, which increases expiratory pressure and keeps the airway open, preventing disruption in breathing. Provent Therapy is approved by Health Canada, is FDA cleared and has CE marking. For more information, please visit www.proventtherapy.ca

About Ventus Medical

Ventus Medical is a privately-held medical device company dedicated to providing non-invasive medical solutions for people with sleep-disordered breathing. Based on its innovative MicroValve technology and patented designs, Ventus has developed a unique line of clinically-proven medical devices to address the continuum of sleep disorders from severe obstructive sleep apnea (OSA) to mild snoring. Ventus Medical devices work by creating expiratory positive airway pressure (EPAP). The company markets Provent® Therapy, a discreet, easy-to-use nasal device, for the treatment of OSA in the United States, Australia, New Zealand, Hong Kong, Singapore and Malaysia, and also markets an over-the-counter device for snoring in the United States. www.ventusmedical.com.

About ioSleep Inc.

ioSleep is a Canadian distributor of innovative solutions for patients suffering from sleep disorders.   Dedicated to supporting both the Canadian healthcare pro
'/>"/>

SOURCE Ventus Medical
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
3. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
4. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
5. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
6. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
7. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
8. Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro™ for Treatment of Chronic Pain
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ... the Jefferies 2015 Healthcare Conference on Wednesday, June 3, ... New York .  Lexicon management will provide an ... A webcast of the presentation will be available ... version of the presentation will be available at ...
(Date:5/28/2015)... and DEKALB, Ill. , May ... Letter of Intent to explore an affiliation with ... months, KishHealth and NMHC will further define the ... approval. "KishHealth is recognized for their ... said Dean M. Harrison , President and ...
(Date:5/28/2015)... Today, the California State Senate approved legislation ... before prescribing the most addictive medications to help prevent ... SB 482, authored by Sen. Ricardo Lara ... prescribers to check the Controlled Substance Utilization Review and ... drugs, like OxyContin and other opioids, for the first ...
Breaking Medicine Technology:Lexicon To Present At The Jefferies 2015 Healthcare Conference 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 3California Senate Approves Legislation Requiring Physicians To Check State Database Before Prescribing Powerful, Addictive Medications, Says Consumer Watchdog 2
... one of the world,s leading research and advisory firms ... of branded erythropoietin stimulating agent (ESA) market share is ... the United States compared to biosimilar erosion seen in ... 2007. According to Biosimilars Advisory Service: ...
... YORK, Nov. 4, 2010 Reportlinker.com ... report is available in its catalogue: ... Cancer Overview - Metastatic gastrointestinal cancers ... to a lack of approved drugs ...
Cached Medicine Technology:Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe 2Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 2Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 3Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 4Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 5Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 6Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 7Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 8Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 9Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 10Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 11Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 12Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 13Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 14Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 15Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 16Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs 17
(Date:5/29/2015)... Astoria, NY (PRWEB) May 29, 2015 Thursday, ... United States. People from all walks of life came ... , Because Red Nose Day is a campaign dedicated to ... by simply having fun and making people laugh, the people ... their clinic in Astoria. Here they provided food, fun ...
(Date:5/29/2015)... Acoustiblok recently resolved a noisy well motor ... Valleys Municipal Water District (Three Valleys MWD) in California. ... the project said, “The new Acoustiblok All Weather Sound ... much better looking than the temporary barriers. We are ... throughout the process, and the customer service was great.” ...
(Date:5/29/2015)... MA (PRWEB) May 29, 2015 ... investigators from the Clinical Proteomic Tumor Analysis Consortium ... Tryptides™, a new product line of peptide ... catalog of Tryptides™, or isotope labeled tryptic peptides, ... of interest and is now readily accessible to ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 On May ... 2015 cheap bridesmaid dresses and party dresses. Most of ... $100. Their new release includes more than 80 styles ... , The most popular design elements coming with ... patterns and chic one shoulder design. Many of the ...
(Date:5/28/2015)... (PRWEB) May 29, 2015 On Monday, June ... newest location at 160 Frankfort Road in Shelbyville, Kentucky . ... all operations as well as treat patients , “ ... a more convenient , local clinic to better serve the ... first making their experience as trouble-free as possible by providing ...
Breaking Medicine News(10 mins):Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 4Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 5Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3
... ... spirit and is virtually giving away a very popular marketing tool. $1 gets chiropractors ... chiropractic promotional templates free of cost. , ... (PRWEB) December 3, 2009 -- Chiropractic Marketing Group ...
... N.J., Dec. 3 The development of University Medical ... today with a "topping out" ceremony, marking the completion ... replace University Medical Center at Princeton (UMCP). , (Photo: ... a steelworkers, tradition in which a steel beam carrying ...
... , CHICAGO, Dec. 3 The American Medical ... Court for the Southern District of New York has ... settlement that would resolve a class-action lawsuit against UnitedHealth ... Society of the State of New York and Missouri ...
... weeks and includes minimally invasive procedures, study finds , THURSDAY, ... surgery are a much greater risk than has previously been ... is that not only is the risk higher, but that ... Jane Green, a clinical epidemiologist at the University of Oxford ...
... of diabetes, cardiovascular disease, researchers say , THURSDAY, Dec. ... glucose (blood sugar) intolerance are at increased risk ... says a new study. , Gestational glucose intolerance is ... a group of factors (including high blood pressure, obesity ...
... about whether they cause brain cancer, , THURSDAY, Dec. 3 ... been a subject of ongoing debate, but a new study ... examination of the incidents of brain tumors in Scandinavia found ... became widespread, according to the report in the Dec. 3 ...
Cached Medicine News:Health News:New Chiropractic Marketing: A $1 Chiropractic Marketing Tool that Can Make Users $1000s 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2Health News:Blood Clot Threat After Surgery Worse Than Thought 2Health News:Blood Clot Threat After Surgery Worse Than Thought 3Health News:Blood Sugar Intolerance May Predict Postpartum Ills 2Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: